Home > Income Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Revenue

    Back to Income Statement
PIRAMAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021
Net Sales ₹8,171 Cr₹7,082 Cr₹6,559 Cr₹6,315 Cr

What is the latest Revenue of PIRAMAL PHARMA ?

The latest Revenue ratio of PIRAMAL PHARMA is ₹8,171 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹8,171 Cr
Mar2023₹7,082 Cr
Mar2022₹6,559 Cr
Mar2021₹6,315 Cr

How is Revenue of PIRAMAL PHARMA Trending?

Years Revenue % Change
Mar2024 ₹8,171 Cr
15.39
Mar2023 ₹7,082 Cr
7.97
Mar2022 ₹6,559 Cr
3.87
Mar2021 ₹6,315 Cr -

Compare Revenue of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹26,577.4 Cr -3.1% -8.7% 36.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,768.0 Cr 0.4% -1.2% 12.2% Stock Analytics
DIVIS LABORATORIES ₹178,468.0 Cr 2.6% 8.4% 48.5% Stock Analytics
CIPLA ₹121,326.0 Cr -0.1% 0.5% 1.7% Stock Analytics
DR REDDYS LABORATORIES ₹113,757.0 Cr 3.2% 11.8% 11.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,345.0 Cr 3.4% 0.5% 12.8% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-3.1%

-8.7%

36.3%

SENSEX

0.3%

0.7%

8.8%


You may also like the below Video Courses